Literature DB >> 1081929

In vitro differentiation of human marrow cells into T lymphocytes by thymic extracts using the rosette technique.

G S Incefy, P L'Esperance, R A Good.   

Abstract

The manner by which human and calf thymic extracts induce precursor cells of human marrow to differentiate in vitro into T lymphocytes has been studied using as a T-cell marker the spontaneous rosette formation technique of human T lymphocytes with sheep erythrocytes (E rosette). These findings confirm previous observations made in the study of the same process using a different T-cell marker, specific antigenicity recognizable by a heterologous anti-human T-cell serum in a microcytotoxicity test. The number of cells revealing evidence of differentiation demonstrated by the E rosette formation technique is smaller than that obtained with the anti-human T-cell serum, indicating perhaps that a different stage of maturation of T lymphocytes is recognized by the antiserum from the one detected by spontaneous rosette formation. Based on the effects of specific inhibitors of nucleic acids and protein synthesis, it can be concluded that these thymic extracts ultimately act by influences exerted in the cell nucleus and that RNA and protein synthesis are required for the differentiation of precursor cells into T lymphocytes induced by thymic extracts. In addition, continued protein synthesis appears to be required for maintenance of receptors for sheep erythrocytes on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081929      PMCID: PMC1538153     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  INHIBITION BY PUROMYCIN OF AMINO ACID INCORPORATION INTO PROTEIN.

Authors:  M B Yarmolinsky; G L Haba
Journal:  Proc Natl Acad Sci U S A       Date:  1959-12       Impact factor: 11.205

2.  Lymphocyte populations: separation by discontinuous density gradient centrifugation.

Authors:  D T Yu; B J Peter; H E Paulus; H I Machleder
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

3.  Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts.

Authors:  J L Touraine; G S Incefy; F Touraine; Y M Rho; R A Good
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

4.  Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus.

Authors:  R S Basch; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

5.  Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone.

Authors:  J F Bach; M Dardenne; A L Goldstein; A Guha; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

6.  Adaptation of albumin density gradient centrifugation to human bone marrow fractionation.

Authors:  K A Dicke; P H Lina; D W van Bekkum
Journal:  Rev Eur Etud Clin Biol       Date:  1970-03

7.  In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes.

Authors:  K Komuro; E A Boyse
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

8.  Rosette formation, a test for cellular immunity.

Authors:  J Wybran; H H Fudenberg
Journal:  Trans Assoc Am Physicians       Date:  1971

9.  Heterologous specific antiserum for identification of human T lymphocytes.

Authors:  J L Touraine; F Touraine; D F Kiszkiss; Y S Choi; R A Good
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

Review 10.  Actinomycin and nucleic acid function.

Authors:  E Reich; I H Goldberg
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1964
View more
  10 in total

1.  Augmentation of mitogen responsiveness in human lymphocytes by a humoral factor obtained from thymic epithelial cultures.

Authors:  E J Hensen; E C Hoefsmit; J G Van Den Tweel
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

2.  The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.

Authors:  M G Bernengo; G Capella; A de Matteis; P A Tovo; G Zina
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

3.  Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.

Authors:  J J Twomey; G Goldstein; V M Lewis; P M Bealmear; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

4.  Age-related changes in human thymus.

Authors:  J Singh; A K Singh
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

5.  Evaluation of functional thymic hormones in Arabian horses with severe combined immunodeficiency.

Authors:  G A Splitter; G Incefy; T Iwata; T C McGuire
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

6.  T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells.

Authors:  R N Pahwa; S G Pahwa; R A Good
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

7.  Thymic activity in severe combined immunodeficiency diseases.

Authors:  G S Incefy; M Dardenne; S Pahwa; E Grimes; R N Pahwa; E Smithwick; R O'Reilly; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

8.  Heterogeneity of stem cells in severe combined immunodeficiency.

Authors:  G S Incefy; E Grimes; W A Kagan; G Goldstein; E Smithwick; R O'Reilly; R A Good
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

9.  Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.

Authors:  R Pahwa; S Pahwa; R A Good; G S Incefy; R J O'Reilly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

10.  Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor, FTS.

Authors:  G S Incefy; R Mertelsmann; K Yata; M Dardenne; J F Bach; R A Good
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.